RSS

schizophrenia

A collaboration between healthcare solutions provider, Novartis, and Pear Therapeutics has been announced that aims to develop digital therapeutics for patients with schizophrenia and multiple sclerosis (MS). more

Technology

Real world evidence from a study involving almost 30,000 people, supporting the benefits of long-acting antipsychotics (LATs) in reducing the risk of mortality among schizophrenic patients, has been announced by Janssen Pharmaceutical more

News

The US Food and Drug Administration (FDA) has approved a drug with an ingestible sensor embedded in it that can record if the medication is ingested or not. more

Technology

A new pipeline drug, RBP-7000, developed by Indivior for the treatment of schizophrenia, has the potential to improve patient compliance, according to research performed by consulting firm GlobalData. more

News

In June 2013, Almac hosted Otsuka America Pharmaceutical Inc.’s (OAPI) Clinical Trial Supply team at Almac’s North American Headquarters in Souderton, Pennsylvania, US. The highlight of the meeting was a presentation of an award to the Almac... more

Technology